Work

Phase I/II Clinical Trial of Temsirolimus and Lenalidomide in Patients with Relapsed and Refractory Lymphomas

Year: 2020

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood-2020-134750

Authors: Ajay Major, Justin Kline, Theodore G. Karrison, Paul A S Fishkin, Amy S Kimball, Adam M Petrich, Sreenivasa Nattam, Bethany G Sleckman, Kenneth Cohen, Koen van Besien, Aaron P. Rapoport, Sonali M. Smith

Institutions: University of Chicago, Illinois CancerCare, University of Maryland, Baltimore, Amgen (United States), University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Northwestern University, Daiichi Sankyo (United States), Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Hematology Oncology Associates of Fredericksburg, New York Oncology Hematology, Sisters of Mercy Health System, Mercy Hospital, Weill Cornell Medicine

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3097001535

FWCI: 0.493

Cites:

Cited by: 3

Related to: 10